Bangladesh's first native Covid vaccine Bangavax receives nod for human trials

ANI
24 Nov 2021, 16:25 GMT+10

Dhaka [Bangladesh], November 24 (ANI): Bangladesh's first homegrown vaccine has received approval from the Bangladesh Medical Research Council (BMRC) for human trials.

Senior manager for quality and regulation AT Directorate General of Drug Administration (DGDA) stated that the manufacturer of Bangavax, Globe Biotech is set to send DGDA human trial protocol, reported the Daily Star.

After the single-dose vaccine, Bangavax gets assent for clinical trials from DGDA, Globe Biotech will initiate human trials, said DGDA senior manager.

Globe Biotech on October 5 the previous year, revealed that its first vaccine candidate had shown promise in pre-clinical trials on mice, reported the Daily Star.

Bangavax was initially known as Bancovid. (ANI)

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Nepal National.

More Information

null in null

Business

Section

AI saves $500 million for Microsoft as layoffs reshape strategy

REDMOND, Washington: Artificial intelligence is transforming Microsoft's bottom line. The company saved over US$500 million last year...

FTC’s rule to ease subscription cancellations struck down by court

WASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...

Musk’s X loses CEO Linda Yaccarino amid AI backlash, ad woes

BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...

Ex-UK PM Sunak takes advisory role at Goldman Sachs

NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...

Gold ETF inflows hit 5-year high as tariffs drive safe-haven bets

LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...

PwC: Copper shortages may disrupt 32 percent of chip output by 2035

AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...

Southeast Asia

Section